The data presented in this study show that there is a significant concordance between the detection of CK-19 mRNA-positive cells detected in the peripheral blood (CTCs) and in bone marrow (DTCs) of patients with early breast cancer, both before initiation and after completion of adjuvant chemotherapy. The gene discussed is KRT19; the disease is breast cancer.